|
Re: Random thoughts RVX-208 and COVID-19
|
2
|
Resverlogix Corp.
|
Apr 13, 2020 02:31PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
5
|
Resverlogix Corp.
|
Sep 07, 2019 03:24PM
|
|
Re: Question about Phase 2
|
2
|
Resverlogix Corp.
|
Mar 12, 2019 09:08AM
|
|
Re: Question about Phase 2
|
2
|
Resverlogix Corp.
|
Mar 12, 2019 09:38AM
|
|
Re: Question about Phase 2
|
1
|
Resverlogix Corp.
|
Mar 12, 2019 10:23AM
|
|
Re: Question about Phase 2
|
6
|
Resverlogix Corp.
|
Mar 12, 2019 11:36AM
|
|
Re: Q4 2019 Events
|
1
|
Resverlogix Corp.
|
Oct 07, 2019 08:10PM
|
|
Re: Q4 2019 Events
|
1
|
Resverlogix Corp.
|
Oct 07, 2019 09:06PM
|
|
Re: Predictions ......
|
1
|
Resverlogix Corp.
|
Nov 15, 2019 04:37PM
|
|
Re: Potential market
|
9
|
Resverlogix Corp.
|
Nov 17, 2019 04:11PM
|
|
Re: Possible FDA already has eGFR information
|
4
|
Resverlogix Corp.
|
Feb 20, 2020 08:04AM
|
|
Re: Positives vs. negatives
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 01:58PM
|
|
Re: Positives vs. negatives
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 05:54PM
|
|
Re: Position Sizing and Odds of Success
|
4
|
Resverlogix Corp.
|
Apr 25, 2019 08:35PM
|
|
Re: Position Sizing and Odds of Success
|
4
|
Resverlogix Corp.
|
Apr 26, 2019 12:21PM
|
|
Re: Position Sizing and Odds of Success
|
6
|
Resverlogix Corp.
|
Apr 25, 2019 10:59AM
|
|
Re: Pfizer's plans for research: sounds like RVX!
|
8
|
Resverlogix Corp.
|
Jan 29, 2020 12:09PM
|
|
Re: Patient Years & MACE rate Question
|
1
|
Resverlogix Corp.
|
Jul 11, 2019 09:54AM
|
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 10:37AM
|
|
Re: Patient Years & MACE rate Question
|
7
|
Resverlogix Corp.
|
Jul 11, 2019 10:47AM
|
